A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma

Clinical trial NCT02087878 · WITHDRAWN

Trial details

NCT number: NCT02087878
Sponsor: AbbVie
Status: WITHDRAWN
Study type: OBSERVATIONAL

Crohn's Disease Ulcerative Colitis (UC)Hepatosplenic T-Cell Lymphoma

Start date: 2014-03-31
Primary completion: 2019-09-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.